TROUT HARRY R. III (Vice President, Finance) sold 2.2% of their position (380.00 shares) of ENANTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $5.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/3/2025ACC: 0002064832-25-000050
Officer· Vice President, Finance
Since Aug 2025
-485.00
Net shares
Net seller
$6.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
485.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−105.00
Price / share
$14.12
Trade value
$1.48K
% of position
0.6%
12/1/2025
17.38K→17.27K
Common Stock
Direct
Shares
−380.00
Price / share
$13.96
Trade value
$5.30K
% of position
2.2%
12/2/2025
17.27K→16.89K
Total
Net shares
−485.00
Net value
-$6.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | F · Tax Withholding | −105.00 | $14.12 | $1.48K | 0.6% | 17.38K | 17.27K |
| Common Stock Direct | 12/2/2025 | S · Sale | −380.00 | $13.96 | $5.30K | 2.2% | 17.27K | 16.89K |
| Total | −485.00 | -$6.79K | ||||||
Derivative Transactions0
No derivative transactions reported